Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-08

Clinical Trial Update: Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating progesterone to improve management of preterm severe or superimposed preeclampsia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Pregnancy, Preeclampsia (PE) | Phase 2 | Status: RECRUITING